Otsuka
We believe in challenging the norm and taking innovative approaches to creating new medicines. That drive has helped us develop transformative treatments for patients within several disease areas: oncology, nephrology, cardio-renal and, especially mental health. More than 2,000 employees strong in the U.S., Otsuka is striving to improve the health of millions of Americans and patients worldwide.
RELATED ARTICLES
Researcher Profile: Eva Kohegyi
Dr. Eva Kohegyi specializes in research for medications in neurologic and psychiatric indications, i…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Jirong Lu
Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.
READ MORE
We Cannot Take Progress for Granted
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE